王子新材(002735.SZ):重慶富易達擬將河南富易達34%股權轉讓給阿萊西澳
格隆匯 12 月 22日丨王子新材(002735.SZ)公佈,公司控股子公司重慶富易達科技有限公司(“重慶富易達”)擬與浙江阿萊西澳智能裝備科技有限公司(“阿萊西澳”)簽署《股權轉讓協議書》。重慶富易達擬將其所持有河南富易達科技有限公司(“河南富易達”)34%股權(實繳出資額0元)以1元價格轉讓給阿萊西澳,並由阿萊西澳承擔並履行剩餘認繳出資680萬元人民幣的實繳出資義務;河南富易達其他股東放棄優先購買權。上述股權轉讓完成後,重慶富易達持有河南富易達51%股權,河南富易達仍為公司二級控股子公司。同時授權管理層處理此次投資有關事宜。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.